 | • レポートコード：MRC2103G049 • 出版社/出版日：Transparency Market Research / 2020年10月23日 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、世界の止血剤・組織閉鎖剤市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（局所止血鉗子別、接着剤・組織閉鎖剤）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・止血剤・組織閉鎖剤の世界市場規模：種類別（局所止血鉗子別、 接着剤・組織閉鎖剤） ・止血剤・組織閉鎖剤の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Global Hemostasis and Tissue Sealing Agents Market – Scope of Report
TMR’s report on the global hemostasis and tissue sealing agents market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global hemostasis and tissue sealing agents market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global hemostasis and tissue sealing agents market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global hemostasis and tissue sealing agents market.
Secondary research also included internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global hemostasis and tissue sealing agents market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global hemostasis and tissue sealing agents market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global hemostasis and tissue sealing agents market.
The report delves into the competitive landscape of the global hemostasis and tissue sealing agents market. Key players operating in the global hemostasis and tissue sealing agents market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global hemostasis and tissue sealing agents market that have been profiled in this report.
Key Questions Answered in Global Hemostasis and Tissue Sealing Agents Market Report
What is the scope of growth of product companies in the global hemostasis and tissue sealing agents market?
What will be the Y-o-Y growth of the global hemostasis and tissue sealing agents market between 2019 and 2027?
What is the influence of changing trends in technologies on the global hemostasis and tissue sealing agents market?
Will North America continue to be the most profitable market for hemostasis and tissue sealing agents providers?
Which factors are anticipated to hamper the growth of the global hemostasis and tissue sealing agents market during the forecast period?
Which are the leading companies in the global hemostasis and tissue sealing agents market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global hemostasis and tissue sealing agents market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global hemostasis and tissue sealing agents Market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the hemostasis and tissue sealing agents market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the hemostasis and tissue sealing agents market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global hemostasis and tissue sealing agents market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global hemostasis and tissue sealing agents market more reliably and accurately.
Regional Segmentation of Hemostasis and Tissue Sealing Agents Market
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemostasis and Tissue Sealing Agents Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Development in the Market
5.2. Mergers & Acquisitions
5.3. COVID-19 Impact Analysis
6. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Type, 2017–2027
6.2.1. Topical Hemostat
6.2.1.1. Mechanical Hemostats
6.2.1.1.1. Collagen based Topical Hemostats
6.2.1.1.2. ORC based Topical Hemostats
6.2.1.1.3. Gelatin based Topical Hemostats
6.2.1.1.4. Polysaccharide based Topical Hemostats
6.2.1.2. Active Hemostats
6.2.1.3. Flowable Hemostats
6.2.2. Adhesive and Tissue Sealing Agents
6.2.2.1. Natural Tissue Sealant
6.2.2.2. Synthetic Tissue Sealant
6.2.2.3. Adhesion Barrier Products
6.3. Global Hemostasis and Tissue Sealing Agents Market Analysis, by Type
6.4. Global Hemostasis and Tissue Sealing Agents Market Attractiveness, by Type
7. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. North America Hemostasis and Tissue Sealing Agents Market Attractiveness, by Region
8. North America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
8.2.1. Topical Hemostat
8.2.1.1. Mechanical Hemostats
8.2.1.1.1. Collagen based Topical Hemostats
8.2.1.1.2. ORC based Topical Hemostats
8.2.1.1.3. Gelatin based Topical Hemostats
8.2.1.1.4. Polysaccharide based Topical Hemostats
8.2.1.2. Active Hemostats
8.2.1.3. Flowable Hemostats
8.2.2. Adhesive and Tissue Sealing Agents
8.2.2.1. Natural Tissue Sealant
8.2.2.2. Synthetic Tissue Sealant
8.2.2.3. Adhesion Barrier Products
8.3. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country, 2017–2027
8.3.1. U.S.
8.3.2. Canada
8.4. North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
8.4.1. By Type
8.4.2. By Country
9. Europe Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
9.2.1. Topical Hemostat
9.2.1.1. Mechanical Hemostats
9.2.1.1.1. Collagen based Topical Hemostats
9.2.1.1.2. ORC based Topical Hemostats
9.2.1.1.3. Gelatin based Topical Hemostats
9.2.1.1.4. Polysaccharide based Topical Hemostats
9.2.1.2. Active Hemostats
9.2.1.3. Flowable Hemostats
9.2.2. Adhesive and Tissue Sealing Agents
9.2.2.1. Natural Tissue Sealant
9.2.2.2. Synthetic Tissue Sealant
9.2.2.3. Adhesion Barrier Products
9.3. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
9.4. Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
9.4.1. By Type
9.4.2. By Country/Sub-region
10. Asia Pacific Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
10.2.1. Topical Hemostat
10.2.1.1. Mechanical Hemostats
10.2.1.1.1. Collagen based Topical Hemostats
10.2.1.1.2. ORC based Topical Hemostats
10.2.1.1.3. Gelatin based Topical Hemostats
10.2.1.1.4. Polysaccharide based Topical Hemostats
10.2.1.2. Active Hemostats
10.2.1.3. Flowable Hemostats
10.2.2. Adhesive and Tissue Sealing Agents
10.2.2.1. Natural Tissue Sealant
10.2.2.2. Synthetic Tissue Sealant
10.2.2.3. Adhesion Barrier Products
10.3. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
10.4.1. By Type
10.4.2. By Country/Sub-region
11. Latin America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.2.1. Topical Hemostat
11.2.1.1. Mechanical Hemostats
11.2.1.1.1. Collagen based Topical Hemostats
11.2.1.1.2. ORC based Topical Hemostats
11.2.1.1.3. Gelatin based Topical Hemostats
11.2.1.1.4. Polysaccharide based Topical Hemostats
11.2.1.2. Active Hemostats
11.2.1.3. Flowable Hemostats
11.2.2. Adhesive and Tissue Sealing Agents
11.2.2.1. Natural Tissue Sealant
11.2.2.2. Synthetic Tissue Sealant
11.2.2.3. Adhesion Barrier Products
11.3. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America Latin America
11.4. Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
11.4.1. By Type
11.4.2. By Country/Sub-region
12. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.2.1. Topical Hemostat
12.2.1.1. Mechanical Hemostats
12.2.1.1.1. Collagen based Topical Hemostats
12.2.1.1.2. ORC based Topical Hemostats
12.2.1.1.3. Gelatin based Topical Hemostats
12.2.1.1.4. Polysaccharide based Topical Hemostats
12.2.1.2. Active Hemostats
12.2.1.3. Flowable Hemostats
12.2.2. Adhesive and Tissue Sealing Agents
12.2.2.1. Natural Tissue Sealant
12.2.2.2. Synthetic Tissue Sealant
12.2.2.3. Adhesion Barrier Products
12.3. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
12.4.1. By Application
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player – Competition Matrix (by Tier and Size of companies)
13.2. Market Share / Position Analysis, by Company, 2019
13.3. Company Profiles
13.3.1. Advanced Medical Solutions Group plc
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Financial Analysis
13.3.1.3. Growth Strategies
13.3.1.4. SWOT Analysis
13.3.2. Baxter
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Analysis
13.3.2.3. Growth Strategies
13.3.2.4. SWOT Analysis
13.3.3. Cohera Medical, Inc .
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Financial Analysis
13.3.3.3. Growth Strategies
13.3.3.4. SWOT Analysis
13.3.4. CryoLife, Inc .
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Financial Analysis
13.3.4.3. Growth Strategies
13.3.4.4. SWOT Analysis
13.3.5. C.R. Bard, Inc
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Financial Analysis
13.3.5.3. Growth Strategies
13.3.5.4. SWOT Analysis
13.3.6. Johnson & Johnson Services, Inc
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Financial Analysis
13.3.6.3. Growth Strategies
13.3.6.4. SWOT Analysis
13.3.7. Integra LifeSciences Corporation.
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Analysis
13.3.7.3. Growth Strategies
13.3.7.4. SWOT Analysis
13.3.8. Pfizer, Inc.
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Financial Analysis
13.3.8.3. Growth Strategies
13.3.8.4. SWOT Analysis
13.3.9. Cohesion Technologies Inc.
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Financial Analysis
13.3.9.3. Growth Strategies
13.3.9.4. SWOT Analysis
13.3.10. B Braun Medical Inc.
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Financial Analysis
13.3.10.3. Growth Strategies
13.3.10.4. SWOT Analysis
13.3.11. Other prominent Players
Table 01: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017–2027
Table 02: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 03: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 04: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 05: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 07: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 08: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 09: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 10: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country, 2017-2027
Table 11: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 12: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 13: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 14: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 15: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 16: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 17: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 18: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 19: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 20: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 21: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 22: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 23: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 24: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 25: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 26: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 27: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 28: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 29: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 30: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027